VOR Vor Biopharma Inc. - Common Stock
$23,40
Precio · Ago 25, 2026
Fundamentales a fecha de Ago 11, 2026
Rango 52S
$6–$50
39% of range
Calificación del Analista
BUY
13 analysts
Precio Objetivo
$39
+67% upside
P/E (TTM)
-0.5
ROE
83.4%
Margen de Beneficio Neto
—
VOR Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$23.40
Capitalización Bursátil
$1.27B
P/E (TTM)
-0.5
BPA (TTM)
$-70.50
Ingresos (TTM)
—
Rendimiento div.
0.00%
ROE
83.4%
Deuda/Capital
—
Rango 52S
$7 – $50
VOR Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
—
BPA
$-70.50
2021-12-31
→
2025-12-31
Flujo de caja libre
$-144M
2021-12-31
→
2025-12-31
Márgenes
—
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
VOR
Mediana de Pares
P/E (TTM)
-0.5
—
P/B (P/C)
-7.7
5.2
Price / FCF (Precio / FCF)
-8.8
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
VOR
Mediana de Pares
ROA
-229.3%
-44.7%
ROE
83.4%
-51.5%
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
VOR
Mediana de Pares
Current Ratio (Ratio corriente)
18.2
9.5
Quick Ratio (Ratio Rápido)
18.1
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
VOR
Mediana de Pares
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
VOR
Mediana de Pares
Payout Ratio (Ratio de Pago)
0.00%
—
Dividendos Rendimiento, ratio de pago, historial de dividendos, CAGR a 5 años
Rendimiento por Dividendo
0.00%
Ratio de Pago
0.00%
CAGR de Dividendos a 5 años
—
VOR Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
13 analistas
- Compra fuerte 5 38,5%
- Compra 6 46,2%
- Mantener 2 15,4%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
8 analistas · 2026-08-24
Mediana
$40.00
← Por Debajo de Todos los Objetivos
$23.40
Mín
$27.00
Máx
$50.00
Objetivo mediano
$40.00
+70,9%
Objetivo medio
$39.00
+66,7%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-2.6%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 31 de marzo de 2026 | $-5.11 | $-0.79 | -4.3% |
| 31 de diciembre de 2025 | $25.84 | $-1.69 | 27.5% |
| 30 de septiembre de 2025 | $-3.33 | $-3.28 | -0.05% |
| 30 de junio de 2025 | $-43.80 | $-8.86 | -34.9% |
| 31 de marzo de 2025 | $-5.20 | $-4.62 | -0.58% |
| 31 de diciembre de 2024 | $-8.80 | $-5.77 | -3.0% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| VOR | $506M | -0.2 | — | — | 83.4% | — |
| SANA | $1.09B | -4.2 | — | — | -172.3% | — |
| KURA | $913M | -3.3 | 25.2% | -413.0% | -116.2% | — |
| JANX | $833M | -7.5 | -5.5% | -1136.2% | -11.7% | — |
| SVRA | $1.23B | -11.4 | — | — | -73.4% | — |
| AVTX | $336M | -3.1 | -86.6% | -132642.4% | -83.4% | — |
| IMMX | $277M | -5.9 | — | — | -59.8% | — |
| CLYM | $191M | -4.5 | — | — | -34.6% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 12
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $322M | $93M | $94M | $65M | $48M | $32M | |
| SG&A Expense | $50M | $28M | $32M | $29M | $21M | $12M | |
| Operating Expenses | $372M | $121M | $126M | $93M | $69M | $43M | |
| Operating Income | $-372M | $-121M | $-126M | $-93M | $-69M | $-43M | |
| Interest Income | $6M | $4M | $8M | $1M | $119.0K | $29.0K | |
| Other Non-op | $-324M | $4M | $8M | $1M | $119.0K | $29.0K | |
| Net Income | $-696M | $-117M | $-118M | $-92M | $-69M | $-43M | |
| EPS (Basic) | $-70.50 | $-34.03 | $-1.75 | $-2.33 | $-2.10 | · | |
| EPS (Diluted) | $-70.50 | $-34.03 | $-1.75 | $-2.33 | $-2.10 | · | |
| Shares (Basic) | 9,871,866 | 3,435,533 | 67,191,973 | 39,551,420 | 33,433,214 | · | |
| Shares (Diluted) | 9,871,866 | 3,435,533 | 67,191,973 | 39,551,420 | 33,433,214 | · | |
| EBITDA | $-372M | $-121M | $-126M | $-93M | $-69M | · |
Balance general 21
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $396M | $82M | $31M | $58M | $120M | $49M | |
| Short-term Investments | $59M | $10M | $106M | $173M | $88M | $0 | |
| Prepaid Expense | $1M | $4M | $3M | $4M | $5M | $467.0K | |
| Other Current Assets | $2M | $380.0K | $475.0K | $2M | $2M | $100.0K | |
| Current Assets | $458M | $97M | $141M | $237M | $214M | $49M | |
| PP&E (Net) | $533.0K | $7M | $10M | $13M | $7M | $5M | |
| PP&E (Gross) | $558.0K | $18M | $18M | $17M | $9M | $5M | |
| Accum. Depreciation | $25.0K | $11M | $8M | $5M | $2M | $726.0K | |
| Other Non-current Assets | $2M | $2M | $5M | $3M | $3M | $3M | |
| Total Assets | $464M | $143M | $198M | $299M | $243M | $76M | |
| Accounts Payable | $5M | $2M | $815.0K | $2M | $2M | $2M | |
| Accrued Liabilities | $20M | $13M | $11M | $8M | $6M | $6M | |
| Current Liabilities | $25M | $19M | $16M | $13M | $10M | $10M | |
| Capital Leases | $3M | $28M | $32M | $36M | $16M | $17M | |
| Total Liabilities | $628M | $46M | $47M | $49M | $26M | $28M | |
| Common Stock | $18.0K | $13.0K | $7.0K | $7.0K | $4.0K | $1.0K | |
| Retained Earnings | $-1.15B | $-457M | $-340M | $-222M | $-130M | $-61M | |
| AOCI | $41.0K | $22.0K | $-77.0K | $-770.0K | · | · | |
| Stockholders' Equity | $-164M | $97M | $151M | $251M | $216M | $-59M | |
| Liabilities + Equity | $464M | $143M | $198M | $299M | $243M | $76M | |
| Shares Outstanding | 38,720,196 | 6,238,799 | 3,395,072 | 65,996,138 | 37,174,741 | 505,074 |
Flujo de Efectivo 11
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $19M | $10M | $13M | $11M | $4M | $1M | |
| Restructuring | $30M | · | · | · | · | · | |
| Operating Cash Flow | $-143M | $-100M | $-100M | $-85M | $-69M | $-36M | |
| CapEx | $941.0K | $229.0K | $1M | $8M | $4M | $4M | |
| Investing Cash Flow | $-49M | $97M | $71M | $-94M | $-92M | $-4M | |
| Stock Issued | $70M | $275.0K | $5M | $4M | · | · | |
| Net Stock Activity | $70M | $275.0K | $5M | $4M | · | · | |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | |
| Financing Cash Flow | $504M | $53M | $3M | $117M | $233M | $83M | |
| Net Change in Cash | $312M | $51M | $-26M | $-62M | $72M | $42M | |
| Free Cash Flow | $-144M | $-100M | $-101M | $-94M | $-73M | · |
Rentabilidad 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -229.3% | -68.6% | -47.4% | -34.0% | -43.3% | · | |
| ROE | 83.4% | -137.8% | -72.4% | -45.0% | -30.7% | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 18.2 | 5.2 | 9.0 | 18.1 | 21.1 | · | |
| Quick Ratio | 18.1 | 4.9 | 8.8 | 17.6 | 20.4 | · |
Valoración (TTM) 11
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-696M | $-117M | $-118M | $-92M | $-69M | $-43M | |
| Market Cap | $506M | $2.77B | $3.06B | $8.78B | $8.64B | · | |
| P/E | -0.2 | -0.7 | -25.7 | -57.1 | -110.7 | · | |
| P/B | -3.1 | 28.7 | 20.3 | 35.0 | 39.9 | · | |
| P / Tangible Book | · | 28.7 | 20.3 | 35.0 | 39.9 | · | |
| P / Cash Flow | -3.5 | -27.8 | -30.5 | -103.1 | -124.9 | · | |
| P / FCF | -3.5 | -27.7 | -30.1 | -93.8 | -118.3 | · | |
| Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | · | |
| Earnings Yield | -539.0% | -153.3% | -3.9% | -1.8% | -0.90% | · | |
| Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | · | |
| Annual Payout | $0 | $0 | $0 | $0 | $0 | $0 |
Estado de resultados 12
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $26M | $18M | $19M | $14M | $261M | $27M | $25M | $22M | $22M | $24M | $21M | $28M | $24M | $22M | $17M | $17M | |
| SG&A Expense | $22M | $18M | $17M | $14M | $13M | $7M | $6M | $7M | $7M | $8M | $7M | $8M | $8M | $9M | $8M | $7M | |
| Operating Expenses | $48M | $35M | $36M | $28M | $274M | $33M | $31M | $29M | $29M | $32M | $28M | $35M | $32M | $30M | $25M | $24M | |
| Operating Income | $-48M | $-35M | $-36M | $-28M | $-274M | $-33M | $-31M | $-29M | $-29M | $-32M | $-28M | $-35M | $-32M | $-30M | $-25M | $-24M | |
| Interest Income | $4M | $4M | $3M | $2M | $537.0K | $805.0K | $599.0K | $954.0K | $1M | $2M | $2M | $2M | $2M | $2M | $815.0K | $313.0K | |
| Other Non-op | $-15M | $-184M | $1.76B | $-785M | $-1.30B | $805.0K | $599.0K | $954.0K | $1M | $2M | $2M | $2M | $2M | $2M | $815.0K | $313.0K | |
| Net Income | $-63M | $-220M | $1.72B | $-813M | $-1.57B | $-32M | $-31M | $-28M | $-28M | $-31M | $-26M | $-33M | $-30M | $-28M | $-24M | $-24M | |
| EPS (Basic) | $-1.16 | $-5.11 | $63.95 | $-121.63 | $-251.24 | $-5.21 | $-25.12 | $-8.05 | $-0.41 | $-0.45 | $-0.38 | $-0.49 | $-0.45 | $-0.43 | $-0.51 | $-0.63 | |
| EPS (Diluted) | $-1.16 | $-5.11 | $63.95 | $-121.63 | $-251.24 | $-5.21 | $-25.12 | $-8.05 | $-0.41 | $-0.45 | $-0.38 | $-0.49 | $-0.45 | $-0.43 | $-0.51 | $-0.63 | |
| Shares (Basic) | 54,304,456 | 43,011,544 | -246,905,522 | 6,681,794 | 6,263,572 | 6,241,207 | -136,318,102 | 3,423,499 | 68,299,170 | 68,030,966 | -133,714,593 | 67,607,713 | 67,033,150 | 66,265,703 | -73,188,103 | 38,009,022 | |
| Shares (Diluted) | 54,304,456 | 43,011,544 | -246,905,522 | 6,681,794 | 6,263,572 | 6,241,207 | -136,318,102 | 3,423,499 | 68,299,170 | 68,030,966 | -133,714,593 | 67,607,713 | 67,033,150 | 66,265,703 | -73,188,103 | 38,009,022 | |
| EBITDA | $-48M | $-35M | · | $-28M | $-274M | $-33M | · | $-29M | $-29M | · | · | $-35M | $-32M | $-30M | · | $-24M |
Balance general 21
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $108M | $170M | $396M | $160M | $191M | $50M | $82M | $53M | $76M | $45M | $31M | $45M | $32M | $42M | $58M | $61M | |
| Short-term Investments | $358M | $322M | $59M | $10M | $10M | $10M | $10M | $10M | $10M | $63M | $106M | $115M | $155M | $168M | $173M | $75M | |
| Prepaid Expense | $6M | $6M | $1M | $747.0K | $2M | $5M | $4M | $4M | $4M | $4M | $3M | $4M | $4M | $6M | $4M | $5M | |
| Other Current Assets | $3M | $3M | $2M | $1M | $449.0K | $297.0K | $380.0K | $285.0K | $272.0K | $507.0K | $475.0K | $667.0K | $539.0K | $459.0K | $2M | $2M | |
| Current Assets | $475M | $501M | $458M | $172M | $205M | $65M | $97M | $67M | $90M | $112M | $141M | $164M | $191M | $217M | $237M | $143M | |
| PP&E (Net) | $648.0K | $565.0K | $533.0K | $271.0K | $0 | $6M | $7M | $7M | $8M | $9M | $10M | $11M | $11M | $12M | $13M | $13M | |
| PP&E (Gross) | $738.0K | $618.0K | $558.0K | $272.0K | $0 | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $17M | $17M | $17M | |
| Accum. Depreciation | $90.0K | $53.0K | $25.0K | $1.0K | $0 | $12M | $11M | $11M | $10M | $9M | $8M | $7M | $6M | $5M | $5M | $4M | |
| Other Non-current Assets | $2M | $2M | $2M | $269.0K | $420.0K | $2M | $2M | $3M | $3M | $5M | $5M | $4M | $3M | $3M | $3M | $3M | |
| Total Assets | $481M | $507M | $464M | $176M | $205M | $109M | $143M | $116M | $142M | $167M | $198M | $223M | $251M | $278M | $299M | $206M | |
| Accounts Payable | $4M | $1M | $5M | $885.0K | $669.0K | $4M | $2M | $1M | $2M | $2M | $815.0K | $1M | $2M | $3M | $2M | $824.0K | |
| Accrued Liabilities | $20M | $15M | $20M | $18M | $58M | $9M | $13M | $9M | $8M | $7M | $11M | $10M | $7M | $5M | $8M | $6M | |
| Current Liabilities | $25M | $16M | $25M | $19M | $59M | $17M | $19M | $14M | $14M | $13M | $16M | $15M | $13M | $13M | $13M | $11M | |
| Capital Leases | $3M | $3M | $3M | $3M | $0 | $27M | $28M | $29M | $30M | $31M | $32M | $33M | $34M | $35M | $36M | $37M | |
| Total Liabilities | $681M | $657M | $628M | $2.40B | $1.71B | $43M | $46M | $43M | $44M | $44M | $47M | $48M | $47M | $47M | $49M | $48M | |
| Common Stock | $19.0K | $19.0K | $18.0K | $15.0K | $13.0K | $13.0K | $13.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $4.0K | |
| Retained Earnings | $-1.44B | $-1.37B | $-1.15B | $-2.88B | $-2.06B | $-489M | $-457M | $-426M | $-399M | $-371M | $-340M | $-314M | $-281M | $-251M | $-222M | $-198M | |
| AOCI | $-922.0K | $-706.0K | $41.0K | $12.0K | $14.0K | $23.0K | $22.0K | $68.0K | $-70.0K | $-87.0K | $-77.0K | $-280.0K | $-436.0K | $-174.0K | $-770.0K | $-1M | |
| Stockholders' Equity | $-200M | $-150M | $-164M | $-2.23B | $-1.51B | $66M | $97M | $73M | $98M | $123M | $151M | $175M | $204M | $230M | $251M | $159M | |
| Liabilities + Equity | $481M | $507M | $464M | $176M | $205M | $109M | $143M | $116M | $142M | $167M | $198M | $223M | $251M | $278M | $299M | $206M | |
| Shares Outstanding | 54,455,751 | 54,185,582 | 38,720,196 | 9,026,922 | 125,645,952 | 124,851,547 | 6,238,799 | 68,663,065 | 68,357,884 | 68,215,771 | 67,891,311 | 67,785,469 | 67,433,560 | 66,934,897 | 65,996,138 | 38,393,211 |
Flujo de Efectivo 10
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $9M | $9M | $7M | $8M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | $3M | $4M | $4M | $4M | $3M | |
| Restructuring | · | · | $0 | $-1M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-25M | $-38M | $-23M | $-54M | $-35M | $-31M | $-24M | $-23M | $-22M | $-30M | $-24M | $-28M | $-24M | $-24M | $-18M | $-19M | |
| CapEx | $120.0K | $48.0K | $314.0K | $244.0K | $152.0K | $231.0K | $72.0K | $34.0K | $9.0K | $114.0K | $111.0K | $465.0K | $399.0K | $94.0K | $321.0K | $298.0K | |
| Investing Cash Flow | $-37M | $-263M | $-49M | $-244.0K | $646.0K | $-230.0K | $-72.0K | $-34.0K | $53M | $44M | $10M | $41M | $14M | $6M | $-97M | $13M | |
| Stock Issued | · | · | $50M | $20M | $0 | $0 | $-22.0K | $111.0K | $-92.0K | $278.0K | $-15.0K | $392.0K | $579.0K | $4M | $106.0K | $4M | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | · | · | · | · | $4M | · | · | |
| Financing Cash Flow | $-106.0K | $75M | $308M | $22M | $175M | $-606.0K | $53M | $41.0K | $-31.0K | $96.0K | $25.0K | $176.0K | $218.0K | $3M | $112M | $4M | |
| Net Change in Cash | $-62M | $-227M | $236M | $-32M | $141M | $-32M | $29M | $-23M | $31M | $14M | $-14M | $13M | $-10M | $-15M | $-3M | $-2M | |
| Free Cash Flow | · | $-38M | · | · | · | $-31M | · | · | · | · | · | · | · | $-24M | · | · |
Rentabilidad 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -18.3% | -71.3% | · | -556.2% | -907.1% | -23.5% | · | -16.3% | -14.2% | · | · | -15.5% | -12.6% | -11.1% | · | -10.2% | |
| ROE | 7.4% | 520.6% | · | 75.5% | 223.6% | -34.4% | · | -22.2% | -18.4% | · | · | -19.9% | -15.8% | -13.4% | · | -12.2% |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 19.1 | 31.1 | · | 9.2 | 3.5 | 3.9 | · | 4.7 | 6.5 | · | · | 10.7 | 15.1 | 17.2 | · | 12.9 | |
| Quick Ratio | 18.8 | 30.6 | · | 9.0 | 3.4 | 3.6 | · | 4.4 | 6.2 | · | · | 10.4 | 14.7 | 16.7 | · | 12.3 |
Valoración (TTM) 8
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-2.67B | $-2.64B | · | $-2.45B | $-1.66B | $-119M | · | $-119M | $-122M | $-122M | · | $-115M | $-104M | $-97M | · | $-87M | |
| Market Cap | $1.00B | $967M | · | $440M | $4.07B | $1.79B | · | $961M | $1.37B | · | · | $2.87B | $4.17B | $7.20B | · | $3.06B | |
| P/E | -0.0 | -0.1 | · | -0.3 | -1.5 | -1.6 | · | -1.5 | -11.1 | -26.0 | · | -21.2 | -29.6 | -47.8 | · | -34.3 | |
| P/B | -5.0 | -6.4 | · | -0.2 | -2.7 | 27.1 | · | 13.2 | 13.9 | · | · | 16.4 | 20.4 | 31.3 | · | 19.3 | |
| P / Tangible Book | · | · | · | · | · | 27.1 | · | 13.2 | 13.9 | 26.3 | · | 16.4 | 20.4 | 31.3 | · | 19.3 | |
| P / Cash Flow | · | -25.3 | · | · | · | -57.7 | · | · | · | · | · | · | · | -296.8 | · | · | |
| P / FCF | · | -25.2 | · | · | · | -57.3 | · | · | · | · | · | · | · | -295.6 | · | · | |
| Earnings Yield | -2059.4% | -810.0% | · | -292.5% | -65.7% | -63.9% | · | -67.1% | -9.0% | -3.8% | · | -4.7% | -3.4% | -2.1% | · | -2.9% |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Beneficio neto | $-696M | $-117M | $-118M | $-92M | $-69M |
| EPS Diluido | $-70.50 | $-34.03 | $-1.75 | $-2.33 | $-2.10 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio corriente | 18.2 | 5.2 | 9.0 | 18.1 | 21.1 |
| Ratio Rápido | 18.1 | 4.9 | 8.8 | 17.6 | 20.4 |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flujo de caja libre | $-144M | $-100M | $-101M | $-94M | $-73M |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 103 declarantes · $806.9M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 38 (+4 vs trimestre anterior) | 17 (+7 vs trimestre anterior) | 34 (+9 vs trimestre anterior) | 20 (+9 vs trimestre anterior) | +5.6M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| TCG Crossover Management, LLC | $104 441 366 | 5 673 078 | 12,94% | Acciones |
| FMR LLC | $87 405 893 | 4 747 740 | 10,83% | Acciones |
| FCPM III SERVICES B.V. | $75 800 487 | 4 117 354 | 9,39% | Acciones |
| Venrock Adviser, LLC | $55 998 047 | 3 041 719 | 6,94% | Acciones |
| STATE STREET CORP | $48 166 746 | 2 616 336 | 5,97% | Acciones |
| Frazier Life Sciences Management, L.P. | $46 833 917 | 2 543 939 | 5,80% | Acciones |
| RA CAPITAL MANAGEMENT, L.P. | $44 222 569 | 2 402 095 | 5,48% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $38 372 478 | 2 084 328 | 4,76% | Acciones |
| Caligan Partners LP | $35 440 465 | 1 925 066 | 4,39% | Acciones |
| Paradigm Biocapital Advisors LP | $32 217 500 | 1 750 000 | 3,99% | Acciones |
| GREAT POINT PARTNERS LLC | $31 297 000 | 1 700 000 | 3,88% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $16 677 425 | 905 690 | 2,07% | Acciones |
| NEXTBio Capital Management LP | $16 369 509 | 889 164 | 2,03% | Acciones |
| Nantahala Capital Management, LLC | $15 556 450 | 845 000 | 1,93% | Acciones |
| ADAR1 Capital Management, LLC | $12 530 325 | 680 626 | 1,55% | Acciones |
| Logos Global Management LP | $11 966 500 | 650 000 | 1,48% | Acciones |
| Rosalind Advisors, Inc. | $11 940 726 | 648 600 | 1,48% | Acciones |
| NAN FUNG TRINITY (HK) LTD | $11 902 986 | 646 550 | 1,48% | Acciones |
| BRAIDWELL LP | $10 550 845 | 573 104 | 1,31% | Acciones |
| BOOTHBAY FUND MANAGEMENT, LLC | $10 285 704 | 558 702 | 1,27% | Acciones |
| UBS Group AG | $8 937 300 | 485 459 | 1,11% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $7 880 713 | 428 067 | 0,98% | Acciones |
| SPHERA FUNDS MANAGEMENT LTD. | $7 666 237 | 416 417 | 0,95% | Acciones |
| Woodline Partners LP | $6 990 700 | 379 723 | 0,87% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $6 266 101 | 340 364 | 0,78% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $5 535 961 | 300 704 | 0,69% | Acciones |
| Clearline Capital LP | $5 251 931 | 285 276 | 0,65% | Acciones |
| GOLDMAN SACHS GROUP INC | $4 182 623 | 227 193 | 0,52% | Acciones |
| Eversept Partners, LP | $2 755 627 | 149 681 | 0,34% | Acciones |
| BANK OF AMERICA CORP /DE/ | $2 384 942 | 129 546 | 0,30% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2 234 937 | 121 398 | 0,28% | Acciones |
| MARSHALL WACE, LLP | $1 760 788 | 95 643 | 0,22% | Acciones |
| AXIOM INVESTORS LLC /DE | $1 695 653 | 92 105 | 0,21% | Acciones |
| XTX Topco Ltd | $1 521 494 | 82 645 | 0,19% | Acciones |
| CITADEL ADVISORS LLC | $1 328 668 | 72 171 | 0,16% | Acciones |
| VANGUARD GROUP INC | $1 227 401 | 93 838 | 0,15% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1 189 286 | 64 600 | 0,15% | Opción de venta |
| CITIGROUP INC | $1 118 868 | 60 775 | 0,14% | Acciones |
| BlackRock, Inc. | $1 082 103 | 58 778 | 0,13% | Acciones |
| RHUMBLINE ADVISERS | $1 059 081 | 57 528 | 0,13% | Acciones |
| ALPS ADVISORS INC | $1 012 513 | 54 998 | 0,13% | Acciones |
| JOHNSON & JOHNSON | $989 206 | 53 732 | 0,12% | Acciones |
| Rafferty Asset Management, LLC | $898 739 | 48 818 | 0,11% | Acciones |
| Walleye Capital LLC | $858 127 | 46 612 | 0,11% | Acciones |
| ALLIANCEBERNSTEIN L.P. | $685 036 | 37 210 | 0,08% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $681 391 | 37 012 | 0,08% | Acciones |
| Engineers Gate Manager LP | $680 268 | 36 951 | 0,08% | Acciones |
| WELLS FARGO & COMPANY/MN | $667 786 | 36 273 | 0,08% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $607 733 | 33 011 | 0,08% | Acciones |
| Jefferies Financial Group Inc. | $601 326 | 32 663 | 0,07% | Acciones |
| Bank of New York Mellon Corp | $502 133 | 27 275 | 0,06% | Acciones |
| D. E. Shaw & Co., Inc. | $476 819 | 25 900 | 0,06% | Acciones |
| Sarissa Capital Management LP | $467 596 | 25 399 | 0,06% | Acciones |
| PROFUND ADVISORS LLC | $452 720 | 24 591 | 0,06% | Acciones |
| MetLife Investment Management, LLC | $449 977 | 24 442 | 0,06% | Acciones |
| Squarepoint Ops LLC | $427 683 | 23 231 | 0,05% | Acciones |
| Virtus Investment Advisers, LLC | $419 472 | 22 785 | 0,05% | Acciones |
| TUDOR INVESTMENT CORP ET AL | $361 204 | 19 620 | 0,04% | Acciones |
| Scientech Research LLC | $346 623 | 18 828 | 0,04% | Acciones |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $344 451 | 18 710 | 0,04% | Acciones |
| MORGAN STANLEY | $331 030 | 17 981 | 0,04% | Acciones |
| Vanguard Global Advisers, LLC | $330 404 | 17 947 | 0,04% | Acciones |
| Y-Intercept (Hong Kong) Ltd | $317 352 | 17 238 | 0,04% | Acciones |
| JPMORGAN CHASE & CO | $314 656 | 16 917 | 0,04% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $302 918 | 16 454 | 0,04% | Acciones |
| Invesco Ltd. | $299 568 | 16 272 | 0,04% | Acciones |
| FOX RUN MANAGEMENT, L.L.C. | $281 691 | 15 301 | 0,03% | Acciones |
| NEW YORK STATE COMMON RETIREMENT FUND | $263 263 | 14 300 | 0,03% | Acciones |
| Shay Capital LLC | $252 125 | 13 695 | 0,03% | Acciones |
| Police & Firemen's Retirement System of New Jersey | $221 564 | 12 035 | 0,03% | Acciones |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $198 699 | 10 793 | 0,02% | Acciones |
| EntryPoint Capital, LLC | $198 552 | 10 785 | 0,02% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $197 134 | 10 708 | 0,02% | Acciones |
| BARCLAYS PLC | $173 717 | 9 436 | 0,02% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $167 531 | 9 100 | 0,02% | Acciones |
| Nuveen, LLC | $164 309 | 8 925 | 0,02% | Acciones |
| SEI INVESTMENTS CO | $160 500 | 8 714 | 0,02% | Acciones |
| China Universal Asset Management Co., Ltd. | $158 768 | 8 624 | 0,02% | Acciones |
| NORTHERN TRUST CORP | $117 990 | 6 409 | 0,01% | Acciones |
| Legal & General Group Plc | $72 940 | 3 962 | 0,01% | Acciones |
| Ameritas Investment Partners, Inc. | $68 172 | 3 703 | 0,01% | Acciones |
| Russell Investments Group, Ltd. | $59 942 | 3 256 | 0,01% | Acciones |
| GROUP ONE TRADING LLC | $54 549 | 2 963 | 0,01% | Acciones |
| Mirae Asset Global Investments Co., Ltd. | $44 607 | 2 423 | 0,01% | Acciones |
| Global Retirement Partners, LLC | $38 458 | 2 089 | 0,00% | Acciones |
| Pinnacle Wealth Planning Services, Inc. | $36 360 | 1 975 | 0,00% | Acciones |
| Tower Research Capital LLC (TRC) | $32 052 | 1 741 | 0,00% | Acciones |
| ROYAL BANK OF CANADA | $23 000 | 1 259 | 0,00% | Acciones |
| GF FUND MANAGEMENT CO. LTD. | $19 736 | 1 072 | 0,00% | Acciones |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $10 346 | 562 | 0,00% | Acciones |
| DEUTSCHE BANK AG\ | $9 886 | 537 | 0,00% | Acciones |
| Sterling Capital Management LLC | $6 536 | 355 | 0,00% | Acciones |
| Jump Financial, LLC | $5 320 | 289 | 0,00% | Acciones |
| PNC Financial Services Group, Inc. | $5 302 | 288 | 0,00% | Acciones |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $3 314 | 180 | 0,00% | Acciones |
| SIGNATUREFD, LLC | $2 706 | 147 | 0,00% | Acciones |
| PRICE T ROWE ASSOCIATES INC /MD/ | $770 | 41 815 | 0,00% | Acciones |
| WPG Advisers, LLC | $405 | 22 | 0,00% | Acciones |
| Allworth Financial LP | $185 | 10 | 0,00% | Acciones |
| Parallel Advisors, LLC | $92 | 5 | 0,00% | Acciones |
Informantes de la empresa 24 insiders · 10 directivos · 16 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Jean-Paul Kress | CEO and Chairman | 26 de junio de 2025 A | — | 0 | 0 | $0 |
| Robert Ang | PRESIDENT AND CEO | 6 de mayo de 2025 F | 911 318 | 0 | 0 | $0 |
| Sandesh Mahatme | CFO | 5 de diciembre de 2025 A | 0 | 0 | 0 | $0 |
| Han Wook Choi | Chief Financial Officer | 1 de mayo de 2025 F | 51 280 | 0 | 0 | $0 |
| Nathan D. Jorgensen | CHIEF FINANCIAL OFFICER | 6 de mayo de 2024 F | 189 403 | 0 | 0 | $0 |
| Qing Che Zuraw | Chief Development Officer | 17 de julio de 2025 A | 937 080 | 0 | 0 | $0 |
| Tirtha Chakraborty | Chief Sci Off & Head Tech Ops | 6 de mayo de 2025 F | 217 416 | 0 | 0 | $0 |
| Eyal C. Attar | CHIEF MEDICAL OFFICER | 13 de febrero de 2025 S | 126 625 | 0 | 0 | $0 |
| Amy Quinlan | Vice President of Finance | 6 de noviembre de 2024 F | 50 312 | 0 | 0 | $0 |
| Christopher Slapak | Chief Medical Officer | 1 de febrero de 2022 A | — | 0 | 0 | $0 |
| David Zaccardelli | Consejero | 7 de julio de 2026 A | — | 0 | 0 | $0 |
| Wouter Joustra | Consejero | 11 de junio de 2026 A | — | 0 | 0 | $0 |
| Andrew David Levin | Consejero | 11 de junio de 2026 A | — | 0 | 0 | $0 |
| Michel Detheux | Consejero | 11 de junio de 2026 A | — | 0 | 0 | $0 |
| Fouad Namouni | Consejero | 11 de junio de 2026 A | — | 0 | 0 | $0 |
| Alexander Cumbo | Consejero | 11 de junio de 2026 A | — | 0 | 0 | $0 |
| Daniella Beckman | Consejero | 11 de junio de 2026 A | — | 0 | 0 | $0 |
| Erez Kalir | Consejero | 11 de junio de 2026 A | — | 0 | 0 | $0 |
| Sarah Burgess Reed | Consejero | 8 de septiembre de 2025 A | — | 0 | 0 | $0 |
| Joshua Resnick | Consejero | 22 de mayo de 2025 A | — | 0 | 0 | $0 |
| Sven Ante Lundberg | Consejero | 22 de mayo de 2025 A | — | 0 | 0 | $0 |
| David Charles Lubner | Consejero | 22 de mayo de 2025 A | — | 0 | 0 | $0 |
| Matthew R Patterson | Consejero | 22 de mayo de 2025 A | — | 0 | 0 | $0 |
| Kush Parmar | Consejero | 14 de junio de 2022 A | 1 766 634 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 4 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×19 presentaciones | 21 de julio de 2026 | 19,90% | Enmienda | Campaña de la junta directiva | SEC |
| ForGrowth III PA B.V., Forbion Growth Opportunities Fund III Cooperatief U.A., Forbion Growth III Management B.V. | 23 de diciembre de 2025 | 9,99% | Presentación inicial | Campaña de la junta directiva | SEC |
| Reprogrammed Interchange LLC, Reid Hoffman ×9 presentaciones | 17 de octubre de 2025 | 17,60% | Enmienda | — | SEC |
| 5AM Ventures VI, L.P., 5AM Partners VI, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Andrew J. Schwab, Kush Parmar ×3 presentaciones | 9 de julio de 2025 | 3,50% | Enmienda | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 19 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,23% | 28 650 SH | 21 de agosto de 2026 | Diario |
| IWC · iShares Trust | 0,21% | 140 452 SH | 21 de agosto de 2026 | Diario |
| LABU · Direxion Shares ETF Trust | 0,15% | 54 358 NS | 30 de abril de 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,08% | 3 174 SH | 21 de agosto de 2026 | Diario |
| IWO · iShares Trust | 0,04% | 263 868 SH | 21 de agosto de 2026 | Diario |
| BIB · ProShares Trust | 0,03% | 1 536 NS | 31 de mayo de 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,03% | 29 989 SH | 19 de agosto de 2026 | Diario |
| IWM · iShares Trust | 0,03% | 1 039 618 SH | 21 de agosto de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 234 796 SH | 19 de agosto de 2026 | Diario |
| IWN · iShares Trust | 0,02% | 117 050 SH | 21 de agosto de 2026 | Diario |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 15 321 SH | 21 de agosto de 2026 | Diario |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 492 007 SH | 19 de agosto de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 11 048 SH | 19 de agosto de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,01% | 61 141 SH | 19 de agosto de 2026 | Diario |
| ONEQ · Fidelity Commonwealth Trust | 0,00% | 13 777 NS | 31 de mayo de 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 67 752 SH | 21 de agosto de 2026 | Diario |
| IWV · iShares Trust | 0,00% | 12 987 SH | 21 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 550 885 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3 390 SH | 19 de agosto de 2026 | Diario |